UIC/NIH Center for Botanical Dietary Supplements Research, Program for Collaborative Research in the Pharmaceutical Sciences (PCRPS), and Department of Pharmaceutical Sciences (M/C 781), College of Pharmacy, University of Illinois at Chicago, 833 S. Wood Street, Chicago, Illinois 60612-7231, United States.
Department of Biology, Technische Universität Dresden, Dresden, Germany.
Chem Res Toxicol. 2020 Nov 16;33(11):2793-2803. doi: 10.1021/acs.chemrestox.0c00194. Epub 2020 Oct 12.
Botanical dietary supplements (BDS) containing hops are sold as women's health supplements due to the potent hop phytoestrogen, 8-prenylnaringenin (8-PN), and the cytoprotective chalcone, xanthohumol. Previous studies have shown a standardized hop extract to beneficially influence chemical estrogen carcinogenesis by fostering detoxified 2-hydroxylation over genotoxic 4-hydroxylation estrogen metabolism. In this study, hop extract and its bioactive compounds were investigated for its mechanism of action within the chemical estrogen carcinogenesis pathway, which is mainly mediated through the 4-hydroxylation pathway catalyzed by that can form gentoxic quinones. Aryl hydrocarbon receptor (AhR) agonists induce and , while estrogen receptor alpha (ERα) inhibits transcription of , the enzyme responsible for 2-hydroxylated estrogens and the estrogen detoxification pathway. An In-Cell Western MCF-7 cell assay revealed hop extract and 6-prenylnaringenin (6-PN) degraded ERα via an AhR-dependent mechanism. Reverse transcription PCR and xenobiotic response element luciferase assays showed hop extract and 6-PN-mediated activation of AhR and induction of . A reduction in estrogen-mediated DNA (cytosine-5)-methyltransferase 1 (DNMT1) downregulation of accompanied this activity in a chromatin immunoprecipitation assay. Ultimately, hop extract and 6-PN induced preferential metabolism of estrogens to their detoxified form . These results suggest that the standardized hop extract and 6-PN activate AhR to attenuate epigenetic inhibition of through degradation of ERα, ultimately increasing 2-hydroxylated estrogens. A new mechanism of action rationalizes the positive influence of hop BDS and 6-PN on oxidative estrogen metabolism and, thus, potentially on chemical estrogen carcinogenesis. The findings underscore the importance of elucidating various biological mechanisms of action and standardizing BDS to multiple phytoconstituents for optimal resilience promoting properties.
含有啤酒花的植物性膳食补充剂(BDS)因其含有强效的啤酒花植物雌激素 8-prenylnaringenin(8-PN)和具有细胞保护作用的查尔酮黄腐醇而被作为女性健康补充剂销售。先前的研究表明,标准化的啤酒花提取物可以通过促进解毒的 2-羟化作用而有益于影响化学雌激素致癌作用,而不是遗传毒性的 4-羟化作用雌激素代谢。在这项研究中,研究了啤酒花提取物及其生物活性化合物在化学雌激素致癌途径中的作用机制,该途径主要通过 4-羟化途径介导,该途径可形成遗传毒性醌。芳香烃受体(AhR)激动剂诱导 和 ,而雌激素受体α(ERα)抑制负责 2-羟化雌激素和雌激素解毒途径的 基因的转录。In-Cell Western MCF-7 细胞测定显示,啤酒花提取物和 6-prenylnaringenin(6-PN)通过 AhR 依赖性机制降解 ERα。逆转录 PCR 和外源生物响应元件荧光素酶测定显示,啤酒花提取物和 6-PN 介导 AhR 的激活和 的诱导。在染色质免疫沉淀测定中,这种活性伴随着雌激素介导的 DNA(胞嘧啶-5)-甲基转移酶 1(DNMT1)下调的减少。最终,啤酒花提取物和 6-PN 诱导雌激素优先代谢为其解毒形式 。这些结果表明,标准化的啤酒花提取物和 6-PN 通过降解 ERα 激活 AhR,从而减轻 对雌激素的表观遗传抑制,最终增加 2-羟化雌激素。作用机制的新认识合理化了啤酒花 BDS 和 6-PN 对氧化雌激素代谢的积极影响 ,从而可能对化学雌激素致癌作用产生积极影响。这些发现强调了阐明各种生物作用机制和对多种植物成分进行 BDS 标准化以促进最佳恢复力的重要性。